GLP-1 and dual GIP/GLP-1 receptor agonists such as Wegovy, Ozempic, Saxenda, Mounjaro, and ZepBound work at the hormonal level to regulate appetite, slow gastric emptying, improve satiety, and stabilize blood sugar
Regionally, North America and Europe currently dominate consumption, driven by established healthcare infrastructure and higher disposable income
Combats Chronic Illnesses Glutathiones antioxidant properties may aid in managing chronic conditions like metabolic syndrome, cystic fibrosis, and mild asthma
Many people become more active after losing weight , which is generally very positive for health
They can assess the potential for interactions, monitor your blood sugar closely, and adjust dosages as needed to prevent adverse effects
10.1161/JAHA.120.020734 J